Soliris 300 MG/30 ML vial 30ML
Ended Awarded
- Contract number
- SPE2DX25F6ADQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $40,182
Award facts
- Contract value 100% obligated
- $40,181.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $40,181.84 for Soliris 300 mg/30 mL vials. This award, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. The delivery order represents a single purchase transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 agreement valid through November 2026 that authorizes the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products supporting military healthcare facilities worldwide.
Soliris (eculizumab) is a specialty biologic medication used to treat rare complement-mediated disorders, and this delivery order fulfills the Defense Logistics Agency's pharmaceutical supply requirements for Department of Defense healthcare sites. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of contracts delivering branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military health facilities. The company's status as a woman-owned small business has enabled it to compete effectively in federal procurement markets while maintaining consistent delivery capabilities for specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DX25F6ADQ?
SPE2DX25F6ADQ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 19, 2025.
How much is contract SPE2DX25F6ADQ worth?
The government has obligated $40,182 on SPE2DX25F6ADQ.
Is contract SPE2DX25F6ADQ an order under another contract?
Yes. SPE2DX25F6ADQ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ADQ competed?
The extent of competition for SPE2DX25F6ADQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award